白细胞介素25与儿童哮喘的关系
摘要
支气管哮喘(bronchial asthma)是一种常见的慢性下呼吸道疾病,50%患者在幼年发病。哮喘的发病机制极为复杂,遗传、感染、神经和精神、环境、运动、药物等因素均与其有关,免疫功能紊乱与变态反应在哮喘发病机制中至关重要,各种细胞因子间相互促进和制约对哮喘发病扮演了重要的角色。
出处
《中国实验诊断学》
2013年第7期1285-1286,共2页
Chinese Journal of Laboratory Diagnosis
参考文献6
-
1Kawaguchi M,Adachi M,Oda N,et al. IL-17 cytokin family[J]. J Allergy Clin Immunol, 2004,114 : 1265-1273.
-
2Wang YH,Angkasekwinai P,Lu N,et al. IL-25 augmems type 2 mmune responses by enhancing the expansion andfunctions ofSLP-DC-activated Th2 memory cells [J ]. JEM, 2007, 20,I ( 8 ) : 1837.
-
3王艳丽,黄茂.白介素25与变态反应性气道炎症[J].国际呼吸杂志,2007,27(13):1021-1023. 被引量:3
-
4支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志,2008,31(3):177-185. 被引量:2519
-
5MoinM, AghamohammadiA, GharaviMH, et al. Risk factors lead ing to hospital admission in Iranian asthmatic children [J]. IntAr- chAllergy Immunol, 2008,145(3) : 244.
-
6LiHT,ZhangTT,ZhouH. Combination therapywith the single in- haler salmeterol/ fluticasone propionate versus increased doses of inhaled cortieosteroids in patients with asthma [J]. Respiration, 2007,74(1) :33.
二级参考文献25
-
1Moseley TA, Haudenschild DR, Rose L, et al. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev, 2003, 14:155-174.
-
2Kawaguchi Mio, Mitsuru Ad, Naruhito Oda, et al. IL-17 cytokine family. J Allergy Clin Immunol, 2004,114:1265-1273.
-
3Fort MM,Cheung J,Yen D,et al. IL-25 induces IL-4,IL-5,and IL-13 and Th2-associated pathologies in vivo. Immunity,2001, 15:985-995.
-
4Lee J, Ho WH, Marulka M, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL- 17Rh1. J Biol Chem,2001,276:1660-1664.
-
5Cheung PF, Wong CK, Ip WK, et al. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy,2006,61:878-885.
-
6Al-Tamemi S, Letuve S, Hajoui O, et al. Th2 dependent induction of IL-25 receptors on human B-cell. J Allergy Clin Immunol, 2005, 115 : 892.
-
7Hurst SD,Muchamuel T,Gorman DM,et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol,2002,169:443- 453.
-
8Ikeda K, Nakajima H, Suzuki K, et al. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood, 2003,101:3594-3596.
-
9Tamachi T, Maezawa Y, Ikeda K, et al. Interleukin 25 in allergic airway inflammation. Int Arch Allergy Immunol, 2006, 140 (Suppl 1) :59-62.
-
10Pan G,French D,Mao W,et al. Forced expression of murine IL- 17E induces growth retardation, jaundice, a Th2-baised response, and multiorgan inflammation in mice. J Immunol, 2001,167:6559-6567.
共引文献2520
-
1郑焕珍.孟鲁司特钠联合布地奈德对中重度哮喘患儿血气指标及肺功能的影响[J].中国合理用药探索,2019,0(10):64-66. 被引量:3
-
2吴志强.麻杏石甘汤加味辅助治疗小儿哮喘发作期45例临床观察[J].中医儿科杂志,2018,0(4):32-35. 被引量:7
-
3陈珊,郑丽霞.参苓白术颗粒联合利肺片治疗儿童支气管哮喘缓解期45例临床观察[J].中医儿科杂志,2018,0(3):37-40. 被引量:5
-
4李微娜,王晓雪,郝恒瑞.槐杞黄颗粒联合GINA阶梯方案治疗儿童支气管哮喘对细胞、体液免疫及炎症因子的影响[J].中药材,2022,45(7):1757-1761. 被引量:3
-
5何侣,刘明全,缪航,梁仍乔,刘欢,尹小林.重症监护病房支气管哮喘急性发作患者真菌感染高危因素分析[J].陕西医学杂志,2020,49(3):292-295. 被引量:10
-
6林维进,姜小青,卢成和.调肺运脾化痰祛湿法治疗咳嗽变异性哮喘临床疗效[J].浙江临床医学,2019,21(5):623-625. 被引量:2
-
7高亚敏,刘峰,程果果.哮喘控制测试在哮喘患者用药指导中的应用[J].医学信息(医学与计算机应用),2016,29(32):102-103.
-
8史国玉.哮喘焦虑患者行护理干预的临床价值分析[J].医学信息(医学与计算机应用),2014,0(35):448-448. 被引量:1
-
9董秀红.聚焦解决模式在慢性持续期哮喘患者随访管理中的应用[J].医学信息(医学与计算机应用),2014,0(29):103-104. 被引量:1
-
10涂建.护理干预降低床旁血气机使用故障[J].医学信息(医学与计算机应用),2014,0(29):43-43.
-
1向阳,袁国华,施桂英.幼年系统性红斑狼疮56例分析[J].湖北民族学院学报(医学版),1994,0(2):21-24.
-
2卢志荣,邓应军.小儿支气管肺炎115例临床分析[J].中国社区医师(医学专业),2012,14(1):167-168. 被引量:4
-
3钟丽花.孟鲁司特联合糖皮质激素对哮喘患儿肺功能及血清IL-4和IL-25的影响[J].医学综述,2011,17(18):2859-2860. 被引量:2
-
4徐青,张永梅,李芳,段国威,安肃英,王炜.哮喘患儿血清白细胞介素25的动态变化和意义[J].中华儿科杂志,2008,46(11):867-868.
-
5曹曦文,刘奇石,刘文清,陈锦娥,蔡珠妹,肖少寒.呼吸道病毒感染与小儿支气管哮喘急性发作的关系[J].河北医学,2009,15(6):701-703. 被引量:15
-
6施桂英.幼年脊柱关节病的特点和治疗[J].中国实用儿科杂志,2005,20(10):586-588. 被引量:8
-
7王占奎,赵恒立.幼年发病的滑膜淀粉样变一例[J].中华风湿病学杂志,2009,13(4):286-287.
-
8张江林,黄烽.幼年发病型脊柱关节病的临床特征[J].中华风湿病学杂志,2001,5(2):113-116. 被引量:22
-
9覃肇源,沈振宇,丘小汕,蒋小云,刘美娜.附着点炎性反应相关性关节炎34例临床特征、预后和转归[J].实用儿科临床杂志,2007,22(21):1648-1649. 被引量:2
-
10孙阳,谢立威,杨丽娜,焦林英.支气管哮喘患儿的健康教育[J].吉林医学,2009,30(18):2139-2139.